Clinical Efficacy and Safety of < b > < i > Artesimia annua < /i > < /b > -Sublingual Immunotherapy in Seasonal Allergic Rhinitis Patients Based on Different Intervention Time

Conclusions: This study proved thatA. annua-SLIT can provide equivalent efficacy and safety for SAR patients under the circumstance of accepting the pre-seasonal treatment of 8 –9 or 12–13 weeks, regardless of monosensitization or polysensitization.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research